Patrik D. Seuling, Nathaly S. Czernin, Miriam A. Schiele
{"title":"虚拟现实暴露疗法在治疗公开演讲焦虑症和社交焦虑症中的应用","authors":"Patrik D. Seuling, Nathaly S. Czernin, Miriam A. Schiele","doi":"10.1016/j.nsa.2024.104074","DOIUrl":null,"url":null,"abstract":"<div><p>Virtual Reality (VR) has emerged as a promising tool in the treatment of anxiety disorders, particularly for exposure-based interventions. This literature review summarizes recent research on the efficacy of Virtual Reality Exposure Therapy (VRET) for addressing public speaking anxiety (PSA) and Social Anxiety Disorder (SAD). VRET demonstrates comparable efficacy to traditional <em>in vivo</em> exposure. While VRET exhibits relatively low drop-out rates, challenges related to immersion and sense of presence in the virtual environment remain to be addressed. Additionally, patients' preferences for VRET over <em>in vivo</em> exposure could enhance treatment adherence. The accessibility and cost-effectiveness of VRET render it a valuable therapeutic option, particularly for individuals with limited access to or low acceptance towards traditional therapy options. Self-guided VRET shows promise as an effective treatment approach, but its efficacy and safety necessitate further investigation. Ethical considerations pertaining to data protection and quality control are crucial when employing VRET applications. Careful implementation and monitoring are necessary to ensure patient privacy and safety. In conclusion, VRET holds significant promise as an effective and accessible treatment modality for SAD and PSA, offering new opportunities for prevention and management in the field of anxiety disorders. Continued research and advancements in VRET technology are expected to enhance its potential as a valuable tool in the mental health care landscape.</p></div>","PeriodicalId":100952,"journal":{"name":"Neuroscience Applied","volume":"3 ","pages":"Article 104074"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277240852400139X/pdfft?md5=e676b282f0850dcc1b94b337e373a48c&pid=1-s2.0-S277240852400139X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Virtual Reality exposure therapy in the treatment of public speaking anxiety and social anxiety disorder\",\"authors\":\"Patrik D. Seuling, Nathaly S. Czernin, Miriam A. Schiele\",\"doi\":\"10.1016/j.nsa.2024.104074\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Virtual Reality (VR) has emerged as a promising tool in the treatment of anxiety disorders, particularly for exposure-based interventions. This literature review summarizes recent research on the efficacy of Virtual Reality Exposure Therapy (VRET) for addressing public speaking anxiety (PSA) and Social Anxiety Disorder (SAD). VRET demonstrates comparable efficacy to traditional <em>in vivo</em> exposure. While VRET exhibits relatively low drop-out rates, challenges related to immersion and sense of presence in the virtual environment remain to be addressed. Additionally, patients' preferences for VRET over <em>in vivo</em> exposure could enhance treatment adherence. The accessibility and cost-effectiveness of VRET render it a valuable therapeutic option, particularly for individuals with limited access to or low acceptance towards traditional therapy options. Self-guided VRET shows promise as an effective treatment approach, but its efficacy and safety necessitate further investigation. Ethical considerations pertaining to data protection and quality control are crucial when employing VRET applications. Careful implementation and monitoring are necessary to ensure patient privacy and safety. In conclusion, VRET holds significant promise as an effective and accessible treatment modality for SAD and PSA, offering new opportunities for prevention and management in the field of anxiety disorders. Continued research and advancements in VRET technology are expected to enhance its potential as a valuable tool in the mental health care landscape.</p></div>\",\"PeriodicalId\":100952,\"journal\":{\"name\":\"Neuroscience Applied\",\"volume\":\"3 \",\"pages\":\"Article 104074\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S277240852400139X/pdfft?md5=e676b282f0850dcc1b94b337e373a48c&pid=1-s2.0-S277240852400139X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroscience Applied\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S277240852400139X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience Applied","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277240852400139X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Virtual Reality exposure therapy in the treatment of public speaking anxiety and social anxiety disorder
Virtual Reality (VR) has emerged as a promising tool in the treatment of anxiety disorders, particularly for exposure-based interventions. This literature review summarizes recent research on the efficacy of Virtual Reality Exposure Therapy (VRET) for addressing public speaking anxiety (PSA) and Social Anxiety Disorder (SAD). VRET demonstrates comparable efficacy to traditional in vivo exposure. While VRET exhibits relatively low drop-out rates, challenges related to immersion and sense of presence in the virtual environment remain to be addressed. Additionally, patients' preferences for VRET over in vivo exposure could enhance treatment adherence. The accessibility and cost-effectiveness of VRET render it a valuable therapeutic option, particularly for individuals with limited access to or low acceptance towards traditional therapy options. Self-guided VRET shows promise as an effective treatment approach, but its efficacy and safety necessitate further investigation. Ethical considerations pertaining to data protection and quality control are crucial when employing VRET applications. Careful implementation and monitoring are necessary to ensure patient privacy and safety. In conclusion, VRET holds significant promise as an effective and accessible treatment modality for SAD and PSA, offering new opportunities for prevention and management in the field of anxiety disorders. Continued research and advancements in VRET technology are expected to enhance its potential as a valuable tool in the mental health care landscape.